These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1796822)

  • 41. Humoral autoreactivity directed against surfactant protein-A (SP-A) in rheumatoid arthritis synovial fluids.
    Trinder PK; Hickling TP; Sim RB; Brackertz D; Loos M; Maeurer MJ
    Clin Exp Immunol; 2000 Apr; 120(1):183-7. PubMed ID: 10759781
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IgE antibodies specific for cartilage collagens type II, IX and XI in rheumatic diseases.
    Cooper AL; Snowden N; Woolley DE
    Scand J Rheumatol; 1993; 22(5):207-14. PubMed ID: 8235489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunohistochemical localization of type I, II, III, and IV collagens in the lung.
    Konomi H; Hori H; Sano J; Sunada H; Hata R; Fujiwara S; Nagai Y
    Acta Pathol Jpn; 1981 Jul; 31(4):601-10. PubMed ID: 7282364
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibodies to the collagen-like region of C1q in sera of patients with autoimmune rheumatic diseases.
    Wener MH; Uwatoko S; Mannik M
    Arthritis Rheum; 1989 May; 32(5):544-51. PubMed ID: 2785797
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-C1q autoantibodies in lupus nephritis.
    Sinico RA; Rimoldi L; Radice A; Bianchi L; Gallelli B; Moroni G
    Ann N Y Acad Sci; 2009 Sep; 1173():47-51. PubMed ID: 19758131
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibodies to type IV collagen in rheumatic diseases.
    Petty RE; Hunt DW; Rosenberg AM
    J Rheumatol; 1986 Apr; 13(2):246-53. PubMed ID: 3014140
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Histologic response to intradermal Zyderm and Zyplast (glutaraldehyde cross-linked) collagen in humans.
    Kligman AM; Armstrong RC
    J Dermatol Surg Oncol; 1986 Apr; 12(4):351-7. PubMed ID: 3082955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The immunogenicity of injectable collagen. II. A retrospective review of seventy-two tested and treated patients.
    Cooperman L; Michaeli D
    J Am Acad Dermatol; 1984 Apr; 10(4):647-51. PubMed ID: 6715615
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autoantibodies against C1q in systemic lupus erythematosus are antigen-driven.
    Schaller M; Bigler C; Danner D; Ditzel HJ; Trendelenburg M
    J Immunol; 2009 Dec; 183(12):8225-31. PubMed ID: 20007586
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-collagen autoantibodies are found in women with silicone breast implants.
    Teuber SS; Rowley MJ; Yoshida SH; Ansari AA; Gershwin ME
    J Autoimmun; 1993 Jun; 6(3):367-77. PubMed ID: 8397717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation of type II collagen-induced arthritis in DBA/1 mice by intravenous application of a peptide from the C1q-A chain.
    Maeurer MJ; Trinder PK; Störkel S; Loos M
    Immunobiology; 1992 Jun; 185(1):103-20. PubMed ID: 1398737
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-C1q autoantibodies in murine lupus nephritis.
    Trouw LA; Seelen MA; Visseren R; Duijs JM; Benediktsson H; de Heer E; Roos A; van Kooten C; Daha MR
    Clin Exp Immunol; 2004 Jan; 135(1):41-8. PubMed ID: 14678263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diminished capacity of opsonization and immune complex solubilization, and detection of anti-C1q antibodies in sera from patients with hereditary angioedema.
    Honda D; Ohsawa I; Sato N; Inoshita H; Mano S; Tomino Y; Suzuki Y
    Allergol Int; 2017 Oct; 66(4):603-609. PubMed ID: 28433622
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum A08 C1q antibodies are associated with disease activity and prognosis in Chinese patients with lupus nephritis.
    Pang Y; Tan Y; Li Y; Zhang J; Guo Y; Guo Z; Zhang C; Yu F; Zhao MH
    Kidney Int; 2016 Dec; 90(6):1357-1367. PubMed ID: 27745701
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus.
    Shoenfeld Y; Szyper-Kravitz M; Witte T; Doria A; Tsutsumi A; Tatsuya A; Dayer JM; Roux-Lombard P; Fontao L; Kallenberg CG; Bijl M; Matthias T; Fraser A; Zandman-Goddard G; Blank M; Gilburd B; Meroni PL
    Ann N Y Acad Sci; 2007 Jun; 1108():227-39. PubMed ID: 17899624
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-C1q antibodies in juvenile-onset systemic lupus erythematosus.
    Jesus AA; Silva CA; Carneiro-Sampaio M; Sheinberg M; Mangueira CL; Marie SK; Liphaus BL
    Ann N Y Acad Sci; 2009 Sep; 1173():235-8. PubMed ID: 19758156
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes.
    Trouw LA; Groeneveld TW; Seelen MA; Duijs JM; Bajema IM; Prins FA; Kishore U; Salant DJ; Verbeek JS; van Kooten C; Daha MR
    J Clin Invest; 2004 Sep; 114(5):679-88. PubMed ID: 15343386
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Complement component c1q and anti-c1q antibodies in theory and in clinical practice.
    Potlukova E; Kralikova P
    Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibodies to the minor cartilage collagen type IX in otosclerosis.
    Bujía J; Alsalameh S; Jerez R; Sittinger M; Wilmes E; Burmester G
    Am J Otol; 1994 Mar; 15(2):222-4. PubMed ID: 8172305
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
    Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.